The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A cost-utility analysis of combined durvalumab and tremelimumab in patients with refractory metastatic colorectal cancer (mCRC) and high plasma tumour mutation burden (pTMB): A Canadian Cancer Trials Group (CCTG) study.
 
Monish Ahluwalia
Stock and Other Ownership Interests - Arrowhead Pharmaceuticals; CVS; Merck; Neurocrine Biosciences; Rocket Pharma
Research Funding - Roche
 
Ambika Parmar
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - Bayer; Eisai; Roche Canada
Research Funding - AstraZeneca/MedImmune; Boston Biomedical; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Mirati Therapeutics; Novartis
 
Derek J. Jonker
No Relationships to Disclose
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Eisai; Ipsen; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Nicole Mittmann
No Relationships to Disclose
 
Matthew C. Cheung
No Relationships to Disclose
 
Harriet Feilotter
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Diaceutics; EMD Serono; Janssen Diagnostics; Precision RxDx; Roche Canada
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Diagnostics; Precision RxDx; Roche Canada
Speakers' Bureau - Bayer; EMD Serono
Research Funding - AstraZeneca (Inst); Bayer (Inst); Delphi Diagnostics (Inst); EMD Serono (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Diagnostics; Roche Canada; Thermo Fisher Scientific
 
Jose Gerard Monzon
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Speakers' Bureau - EMD Serono; Novartis
Research Funding - Merck (Inst)
 
Dawn Marie Ng
No Relationships to Disclose
 
Tarek A. Elfiki
No Relationships to Disclose
 
Nazik Hammad
No Relationships to Disclose
 
Frederic Lemay
Leadership - AurKa Pharma; Esperas Pharma; Ocellaris Pharma
Honoraria - AurKa Pharma; Esperas Pharma; Ocellaris Pharma
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Esperas Pharma; Merck; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical; Taiho Pharmaceutical
 
Anouk Tremblay
No Relationships to Disclose
 
Stacey Hubay
No Relationships to Disclose
 
John Gordon Lenehan
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Merck
 
Muhammad Salim
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose